Contact Person
    Helen Pettersson

    Senior Project Manager
    Email: hp@mva.org
    Phone: (M) +45 2337 0040
    LinkedIn

    Academic Drug Discovery

    Welcome to Academic Drug Discovery – how to secure that preclinical findings reach the patients

    The Medicon Valley universities have many research activities within early drug discovery and they offer a wide range of know-how and research within new therapeutic goals and new and innovative methods to develop drugs. These activities can support drug development not only at the universities but also at other life-science institutions/companies in the region. However, there is currently no clear formalized initiative between academic preclinical drug discovery, clinical trials and the region’s life science industry. How can we ensure maximum exchange between preclinical research findings, related knowledge, and technologies from the academia and the life-science industry and thereby facilitate the progression of novel drug candidates so that they reach all the way to patients and create social benefits?

    University of Copenhagen, Lund University, and Medicon Valley Alliance invite you to Academic Drug Discovery – how to secure that preclinical findings reach the patients:

    Date: 23 August 2018
    Time: 8.30 – 16.30
    Venue: Nielsine Nielsen auditorium, The Maersk Tower, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen N
    Cost: Free of charge for MVA members

    Sign up – This event is fully booked. Please sign up to be included on our waiting list

    By strengthening preclinical drug discovery, increasing the number of academic clinical studies, and optimizing trial designs by e.g. including companion diagnostics, important prerequisites to ensure continued growth of the Swedish-Danish life science sector are created. This event intends to serve as a first step in establishing a more effective regional platform for academic/clinical drug research.

    Program

    08.30-09.00

    Registration and networking

    09.00-09.15

    Welcome and introduction
    Petter Hartman, CEO, Medicon Valley Alliance
    Trine Winterø, Vice-Dean for Innovation and External Relations, University of Copenhagen
    Nils Brünner, Professor emeritus & CEO, Scandion Oncology
    Roland Andersson, Professor, Lund University

    09.15-09.35

    NEXT – a public – private partnership to attract clinical trials to Denmark – how do we do and what is needed to ensure attractiveness?
    Britta Smedegaard, Project Director, NEXT

    09.35-09.50

    The patent perspective – Dos and Don’ts
    Jens Viktor Nørgaard, Partner & European Patent Attorney, HØIBERG P/S

    09.50-10.10

    The Drug Discovery & Development platform at SciLifeLab
    Ulrika Warpman Berglund, Project Manager, SciLifeLab

    10.10-10.30

    Drug Discovery research at Lund University
    Roger Olsson, Professor, Lund University

    10.30-11.00

    Coffee and networking

    11.00-11.20

    Drug Discovery research at University of Copenhagen 
    Kristian Strømgaard, Professor, University of Copenhagen

    11.20-11.40

    From academic research to biotech company
    Peter Ellmark, Vice President Discovery, Alligator Bioscience AB

    11.40-12.00

    The industrial perspective 
    Anders Pedersen, Executive Vice President, H. Lundbeck A/S

    12.00-12.20

    Presentation of Novo Nordisk Fundation BioInnovation Institute
    Thomas Nagy, Director, BioInnovation Institute

    12.20-13.15

    Lunch & networking

    13.15-14.45

    Workshop: How to create a formalized platform for academic drug discovery including infrastructure and know-how
    All attendees

    14.45-15.25

    Summary of workshop and next step
    Nils Brünner, Professor, University of Copenhagen

    15.25-15.45

    Panel discussion

    15.45-16.30

    Refreshments and networking

    Deadline for registration is 17th of August, 2018.

    For more information please contact Senior Project Manager Helen Pettersson: hp@mva.org

    In collaboration

    logo uni_copenhagen  logo LU

    mva logo